Geno.Me, a data exchange platform that links a person’s genetic report with their electronic health records, received $400,000 in seed funding from Gateway Capital Partners, the company announced recently.

“Data accessibility in healthcare is an oxymoron because the process for researchers to obtain data is difficult and expensive,” Geno.Me Founder Britt Gottschalk said in a statement. “Geno.Me aims to incentivize its users to share their de-identified health profile while providing the blueprint for the future of precision medicine.”

The company, which will relocate to Milwaukee, plans to use the money to hire new staff and accelerate product development. It also has received investments from HealthX Ventures.